Here are five things to know about the sale:
1. The stock was sold at $79.81 per share for a total transaction topping $1.6 million.
2. Ms. Stryker now owns 174,605 shares of the company’s stock directly, which comes to around $13.9 million.
3. The company reported $1.08 earnings per share in the second quarter of 2014 and $2.36 billion in revenue, relatively flat over the same period last year.
4. Company stock opened at $79.97 on Aug. 12 and the market cap was $30.1 billion. The company’s 52-week range is $66.44 to $86.93.
5. Ms. Stryker previously sold 21,000 shares in July. The first 14,000 shares, sold on July 3, went for $85.37 per share in a $1.2 million transaction. The second 7,000 shares sold on July 7 were priced at $85.19 per share, making the total transaction worth $596,330.
More articles on orthopedic devices:
Acquisitions drive $300+ global device market growth: Orthopedic companies take the lead
8 quick facts from Tornier’s 2Q financial report
Minimus Spine receives CE certificate for TrioJection System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
